ConductScience.org, home

Trial · NCT01483963

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange From Baseline to Day 92 in Active Forward FlexionBaseline, Day 92Active range of motion (AROM) measurement using a goniometer to assess forward flexion in the affected shoulder
SecondaryChange From Baseline to Day 92 in Passive Forward FlexionBaseline, Day 92Passive range of motion (PROM) measurement using a goniometer to assess forward flexion in the affected shoulder
SecondaryChange From Baseline to Day 92 in Active AbductionBaseline, Day 92AROM measurement using a goniometer to assess abduction in the affected shoulder
SecondaryChange From Baseline to Day 92 in Passive AbductionBaseline, Day 92PROM measurement using a goniometer to assess abduction in the affected shoulder
SecondaryChange From Baseline to Day 92 in Active External RotationBaseline, Day 92AROM measurement using a goniometer to assess external rotation in the affected shoulder
SecondaryChange From Baseline to Day 92 in Passive External RotationBaseline, Day 92PROM measurement using a goniometer to assess external rotation in the affected shoulder
SecondaryChange From Baseline to Day 92 in Active Internal RotationBaseline, Day 92AROM measurement using a goniometer to assess internal rotation with the elbow up to 90° abduction in the affected shoulder
SecondaryChange From Baseline to Day 92 in Passive Internal RotationBaseline, Day 92PROM measurement using a goniometer to assess internal rotation with the elbow up to 90° abduction in the affected shoulder
SecondaryChange From Baseline to Day 92 in American Shoulder and Elbow Surgeons (ASES) Composite ScoreBaseline, Day 92
Composite score ranging from 0-100, with 0 being worst pain and function loss, derived from the sum of the scores from pain subscale (11-point NRS where 0=no pain at all and 10=pain) and function subscale (activity questionnaire where 0=unable to do to, 1=very difficult to do, 2=somewhat difficult, and 3=not difficult); adapted from ASES Standardized Shoulder Assessment Form, Patient Self-Evaluation
SecondaryChange From Baseline to Day 92 in ASES Pain SubscaleBaseline, Day 92
Pain subscale score ranging from 0-50, with 0 being greatest pain, derived from participant assessment of pain in response to "How bad is the pain in your affected shoulder today?" on an 11-point numerical rating scale (NRS) where 0=no pain at all and 10=pain as bad as it can be and calculated as (10 - NRS score) x 5); adapted from ASES Standardized Shoulder Assessment Form, Patient Self-Evaluation
SecondaryChange From Baseline to Day 92 in ASES Function SubscaleBaseline, Day 92
Function subscale score ranging from 0-50, with 0 being most dysfunctional, derived from participant assessment of ability to do 10 activities with affected shoulder/arm where 0=unable to do to, 1=very difficult to do, 2=somewhat difficult, and 3=not difficult, and calculated as (cumulative total score for the 10 activity items) × (5/3); adapted from ASES Standardized Shoulder Assessment Form, Patient Self-Evaluation
SecondarySubject Satisfaction With Treatment at Day 92Day 92Participant assessment of satisfaction with treatment rated as very satisfied, quite satisfied, neither satisfied nor dissatisfied, quite dissatisfied, or very dissatisfied.
SecondaryInvestigator Assessment of Improvement With Treatment at Day 92Day 92
Investigator assessment of degree of improvement in severity of the participant's treated shoulder compared with screening rated as very much improved, much improved, minimally improved, no change, minimally worse, much worse, or very much worse.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01483963/registered